12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

BD FocalPoint regulatory update

Source said that the U.K'.s National Health Service (NHS) Cancer Screening Programs approved the use of the "No Further Review" technology on its...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >